Top compounds associated with response to CCP110


Feature Type Standardized
Nominal ANOVA
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.2 3e-08
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.18 4e-08
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.2 4e-08
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 5e-08
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.2 6e-08
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 6e-08
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.18 1e-07
mRNA GW-2580 GDSC1000 pan-cancer AAC 0.19 1e-07
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.19 1e-07
Download CSV